Reviewing Haleon (NYSE:HLN) & Semperit Ag Hld (OTCMKTS:SEIGY)

Semperit Ag Hld (OTCMKTS:SEIGY) and Haleon (NYSE:HLN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Dividends

Semperit Ag Hld pays an annual dividend of $0.07 per share and has a dividend yield of 1.9%. Haleon pays an annual dividend of $0.24 per share and has a dividend yield of 2.6%. Semperit Ag Hld pays out 233.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 61.5% of its earnings in the form of a dividend. Haleon is clearly the better dividend stock, given its higher yield and lower payout ratio.

Insider & Institutional Ownership

6.7% of Haleon shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Semperit Ag Hld and Haleon’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Semperit Ag Hld	0.19%	0.31%	0.14%
Haleon	N/A	N/A	N/A

Earnings & Valuation

This table compares Semperit Ag Hld and Haleon”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semperit Ag Hld	$749.22 million	0.42	$470,000.00	$0.03	126.00
Haleon	$11.03 billion	3.68	$2.20 billion	$0.39	23.37

Haleon has higher revenue and earnings than Semperit Ag Hld. Haleon is trading at a lower price-to-earnings ratio than Semperit Ag Hld, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Semperit Ag Hld and Haleon, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semperit Ag Hld	0	0	0	0	0.00
Haleon	1	2	4	2	2.78

Haleon has a consensus price target of $13.40, suggesting a potential upside of 47.01%. Given Haleon’s stronger consensus rating and higher probable upside, analysts plainly believe Haleon is more favorable than Semperit Ag Hld.

Volatility & Risk

Semperit Ag Hld has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500.

Summary

Haleon beats Semperit Ag Hld on 12 of the 16 factors compared between the two stocks.

About Semperit Ag Hld

Semperit Aktiengesellschaft Holding develops, produces, and sells rubber products for the medical and industrial sectors worldwide. It operates through two segments: Semperit Industrial Applications and Semperit Engineered Applications. The company provides hydraulic and industrial hoses; conveyor belts; escalator handrails; profiles for windows, doors and facades, cable car rings, and ski foils; and products for railroad superstructures and toolmaking; and precision liquid silicone parts. It offers handrails; engineered solutions; and provides elastomer and sealing profiles for windows, doors, and facades; and elastomer and wear-resistant protective sheeting. It serves agriculture, bulk transportation systems, construction, manufacturing, health care, mining and port facilities, shipping, packing, household, renewable energy and power generation, process, steel, and automotive industries. Semperit Aktiengesellschaft Holding was founded in 1824 and is headquartered in Vienna, Austria.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.